发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| CHINA MAINLAND | 43 |
| USA | 43 |
| Italy | 20 |
| England | 18 |
| GERMANY (FED REP GER) | 15 |
| Canada | 14 |
| Spain | 12 |
| South Korea | 10 |
| Japan | 9 |
| Sweden | 9 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| ASTRAZENECA | 7 |
| SUNGKYUNKWAN UNIVERSITY (SKKU) | 7 |
| CAPITAL MEDICAL UNIVERSITY | 6 |
| CENTRAL SOUTH UNIVERSITY | 6 |
| CHINA MEDICAL UNIVERSITY | 5 |
| GUANGZHOU MEDICAL UNIVERSITY | 5 |
| LAVAL UNIVERSITY | 5 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 5 |
| BOEHRINGER INGELHEIM | 4 |
| CIBER - CENTRO DE INVESTIGACION BIOMEDICA EN R... | 4 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Defining the relationship between COPD and CVD: what are... | 29 |
| Role of immune-checkpoint inhibitors in lung cancer | 18 |
| Omalizumab, the first available antibody for biological ... | 15 |
| Biomarkers in the diagnosis of pleural diseases: a 2018 ... | 12 |
| Mepolizumab in the management of severe eosinophilic ast... | 12 |
| Nintedanib in the management of idiopathic pulmonary fib... | 11 |
| Fatigue is highly prevalent in patients with COPD and co... | 11 |
| How will telemedicine change clinical practice in chroni... | 11 |
| Dabrafenib in combination with trametinib in the treatme... | 10 |
| The combination of tezacaftor and ivacaftor in the treat... | 9 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| INT J CHRONIC OBSTR | 19 |
| THER ADV RESPIR DIS | 17 |
| J THORAC DIS | 13 |
| RESP RES | 12 |
| RESP MED | 10 |
| INT J MOL SCI | 9 |
| PULM PHARMACOL THER | 9 |
| COCHRANE DB SYST REV | 8 |
| EUR RESPIR J | 8 |
| EXPERT REV RESP MED | 8 |